Sign In
Buy SAN
$14.10
-0.0100 (-0.0709%)
At Close: Jul 31, 2026
Coinbase’s stock tumbles after SEC warning, Regeneron shares rally, and other stocks on the move
04:55pm, Thursday, 23'rd Mar 2023 MarketWatch
Coinbase, Chewy, Regeneron, Accenture and First Republic were some of the most active shares on Thursday.
The Fed pivot is near, and yield curve inversion has likely peaked. That's usually bad news for stocks, this Fidelity strategist says.
11:49am, Thursday, 23'rd Mar 2023 MarketWatch
Jurrien Timmer, director of global macro at Fidelity Investments, looked at the intersection of yield-curve inversions and the stock market.
Communiqué de presse: Dupixent® pourrait devenir le premier médicament biologique contre la bronchopneumopathie chronique obstructive, après une étude pivot montrant une réduction significative des exacerbations
06:00am, Thursday, 23'rd Mar 2023 GlobeNewswire Inc.
Dupixent® pourrait devenir le premier médicament biologique contre la bronchopneumopathie chronique obstructive, après une étude pivot montrant une réduction significative des exacerbations
Press Release: Dupixent® demonstrates potential to become first biologic to treat COPD by showing significant reduction in exacerbations in pivotal trial
06:00am, Thursday, 23'rd Mar 2023 GlobeNewswire Inc.
Dupixent® demonstrates potential to become first biologic to treat COPD by showing significant reduction in exacerbations in pivotal trial
Communiqué de presse: Dupixent® (dupilumab) : premier et seul médicament ciblé approuvé par la Commission européenne pour le traitement de la dermatite atopique sévère de l’enfant à partir de six mois
06:00am, Tuesday, 21'st Mar 2023 GlobeNewswire Inc.
Dupixent® (dupilumab) : premier et seul médicament ciblé approuvé par la Commission européenne pour le traitement de la dermatite atopique sévère de l’enfant à partir de six mois
Press Release: Dupixent® (dupilumab) approved by European Commission as first and only targeted medicine for children as young as six months old with severe atopic dermatitis
06:00am, Tuesday, 21'st Mar 2023 GlobeNewswire Inc.
Dupixent® (dupilumab) approved by European Commission as first and only targeted medicine for children as young as six months old with severe atopic dermatitis
Law firm in talks with Credit Suisse bondholders about potential lawsuit after $17 billion wipeout
03:42pm, Monday, 20'th Mar 2023 MarketWatch
A white-shoe law firm is working with Credit Suisse bondholders to pursue "possible legal actions" after the value of convertible bonds issued by the bank was written down to zero following the takeov
Press Release: Dupixent® (dupilumab) late-breaking data at AAD show significant improvements in signs and symptoms of moderate-to-severe atopic hand and foot dermatitis
02:00pm, Saturday, 18'th Mar 2023 GlobeNewswire Inc.
Dupixent® (dupilumab) late-breaking data at AAD show significant improvements in signs and symptoms of moderate-to-severe atopic hand and foot dermatitis
Des données de dernière heure sur Dupixent® (dupilumab) présentées au Congrès de l’AAD montrent des améliorations significatives des signes et symptômes de la dermatite atopique des mains et
Santander's Mexico arm to launch digital bank by March 2024
08:18pm, Thursday, 16'th Mar 2023
The Mexican arm of Spain's Banco Santander plans to launch digital lender Openbank by the end of March 2024 to offer checking accounts, credit cards and other services over time, the head of the local
Communiqué de presse : Sanofi réduit de 78% le prix catalogue de Lantus®, son insuline la plus prescrite aux États-Unis, et plafonne à 35 dollars son coût pour tous les patients assurés
08:06pm, Thursday, 16'th Mar 2023 GlobeNewswire Inc.
Press Release: Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance
08:06pm, Thursday, 16'th Mar 2023 GlobeNewswire Inc.Rout in banking shares picks up pace as jitters resurface
09:17am, Wednesday, 15'th Mar 2023
European banking shares were hammered on Wednesday as confidence in the sector already rattled by the collapse of Silicon Valley Bank in the US was knocked further by a fall of more than 25% in the va
Here's what the plummet in European bank stocks mean for U.S. markets
09:07am, Wednesday, 15'th Mar 2023
Peter Boockvar, Bleakley Financial Group CIO and CNBC contributor, joins 'Squawk Box' to make some understanding of the bank stock performance in Europe, if the plummet in European bank stocks has any
Information concerning the total number of voting rights and shares – February 2023
06:27pm, Tuesday, 14'th Mar 2023 GlobeNewswire Inc.
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement
